MarginsXMarginsX
Home › Markets › Health Care › EYE

National Vision Holdings Inc. (EYE)

EYE trades on Nasdaq in Health Care, Ophthalmic Goods. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$18.74
+2.43% on the day
Market cap
$1.5B
Small cap
Revenue · 2025
$2.0B
+9.0% on 2024
Net income · 2025
$29.6M
1.5% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2026-01-03, https://www.sec.gov/Archives/edgar/data/1710155/000162828026014379/0001628280-26-014379-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2026-01-03.

Profile

FieldValue
TickerEYE on Nasdaq
SectorHealth Care
IndustryOphthalmic Goods
CountryUnited States
IPO year2017
SEC CIK0001710155
SEC industry codeOphthalmic Goods
Incorporated inDE

Financials · 2025

LineValue
Revenue$2.0B
Net income$29.6M
Operating income$58.8M
Net margin1.5%
Operating margin3.0%
Revenue growth+9.0%
Cash$38.7M
Total assets$2.0B
P/E (computed)49.4×
P/S (computed)0.7×

Warning signs

Cash runway
Cash-flow positive
$60.0M cash at October 3, 2026
Share count, 1 year
-1.6%
2025-10-24 to 2026-10-30 · -0.2% over 3 years
Going-concern doubt
No
10-Q filed November 12, 2026
Insider net buying, 12 months
-$498K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-12
Cash and burn$60.0M cash; operating cash flow $37.0M a quarter.Report 2026-10-03
Shares outstanding78,067,119 (2026-10-30); 79,309,558 a year earlier; 78,245,619 three years earlier.Cover page 2026-10-30
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorDeloitte & Touche LLP, Atlanta, Georgia, United StatesPCAOB Form AP 2026-03-09
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $776K, sold $1.3M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-10-03
$510.5M$19.2M$65.1M$60.0M$226.9M$2.1B10-Q 2026-11-12
Q2 2026
2026-07-04
$498.8M$12.4M$8.1M$36.0M$230.1M$2.0B10-Q 2026-08-13
Q1 2026
2026-04-04
$543.9M$31.2M$61.7M$67.9M$233.3M$2.0B10-Q 2026-05-14
Q4 2025
2026-01-03
$503.4M$3.3M$13.2M$38.7M$236.5M$2.0B10-K 2026-03-04
Q3 2025
2025-09-27
$487.3M$3.4M$46.6M$56.0M$243.0M$1.9B10-Q 2026-11-12
Q2 2025
2025-06-28
$486.4M$8.7M$54.3M$48.5M$261.2M$1.9B10-Q 2026-08-13
Q1 2025
2025-03-29
$510.3M$14.2M$32.2M$80.0M$334.1M$1.9B10-Q 2026-05-14
Q4 2024
2024-12-28
$437.3M-$28.6M$30.3M$73.9M$337.2M$1.8B10-K 2025-02-26

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B72019-08-09
Latest annual report10-K2026-03-04
Latest quarterly / interim10-Q2026-11-12
Latest current report8-K2026-11-12
Latest proxyDEFA14A2026-05-04

Source: SEC EDGAR submissions feed, 697 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+2.2%
1 month+7.4%
3 months-4.0%
Year to date-29.1%
1 year-22.7%
From 52-week high-37.9%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Ophthalmic Goods

TickerCompanyPriceDayMarket cap
STAASTAAR Surgical Company$26.01-1.44%$1.3B
WRBYWarby Parker Inc.$26.23-4.41%$3.3B
BLCOBausch + Lomb Corporation Common Shares$20.88-1.00%$7.5B
RXSTRxSight Inc.$5.30-0.38%$222.2M
COOThe Cooper Companies Inc.$61.88-1.23%$11.8B
ALCAlcon Inc.$73.64-0.65%$36.8B
LUCYInnovative Eyewear Inc.$0.7820-3.25%$6.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier